Why we refuse to treat smokers
Smokers should stop smoking completely by the time of their first visit.
We will give a strict warning to those who smell cigarettes even after the consultation.
Tobacco not only causes lung cancer, myocardial infarction, and cerebral thrombosis.
It accelerates the aging of all tissues of the human body such as joints, cartilage, bones, blood vessels, and skin.
It has also been shown to be an aggravating factor for osteoporosis.
Patients undergoing treatment for RA become more toxic when tobacco is added to anti-rheumatic drugs, increasing the risk and mortality of infectious diseases such as pneumonia.
Stopping tobacco is the first step in treating RA and bone / joint diseases.
I can't blame you because your constitution, such as being fat, is mostly determined by heredity.
However, tobacco should be stopped with a strong will.
Tobacco also damages the health of those around us and our families due to underflow smoke.
Especially for professions like restaurant staff who spend all day in cigarette smoke, I'm really sorry.
It is estimated that the life span has been shortened considerably.
I think it's a story that doesn't make sense. It's the same as selling your health and working.
I think management and employers have a duty to protect the health of their employees.
Many people have stopped smoking to see our hospital (though I had never thought of it before) and are happy to have stopped smoking.
In addition, we do not hire smokers as well as smokers, and we do not allow smokers to enter or leave the hospital.
Reasons why we refuse to treat smokers 2
Rheumatoid arthritis is hard to heal for smokers
Larger studies have shown that smokers are significantly less likely to improve rheumatoid arthritis than nonsmokers, even with MTX and biopharmacy (anti-TNFα). I will.
Evidence SourceSaedis Saevarsdottir
Arthritis Rheumatism vol 63 Jan 2011
Patients with early rheumatoid arthritis who smoke are less likely tohttp://onlinelibrary.wiley.com/doi/10.1002/art.27758/abstract
respond to treatment with methotrexate and tumor necrosis factor inhibitors: observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatology Register cohorts.